These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2804987

  • 1. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.
    Remick SC, Benson AB, Weese JL, Willson JK, Ramirez G, Wirtanen GW, Alberti DB, Nieting LM, Tutsch KD, Fischer PH.
    Cancer Res; 1989 Nov 15; 49(22):6437-42. PubMed ID: 2804987
    [Abstract] [Full Text] [Related]

  • 2. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
    Schilsky RL, Janisch L, Berezin F, Mick R, Vogelzang NJ, Ratain MJ.
    Cancer Res; 1993 Mar 15; 53(6):1293-6. PubMed ID: 7680282
    [Abstract] [Full Text] [Related]

  • 3. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H, Kornmann M.
    Anticancer Res; 2003 Mar 15; 23(6D):5203-8. PubMed ID: 14981990
    [Abstract] [Full Text] [Related]

  • 4. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952
    [Abstract] [Full Text] [Related]

  • 5. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ, Newman EM, Doroshow JH, McGonigle K, Margolin K, Raschko J, Chow W, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Carroll M, Vasilev S, Akman S, Coluzzi P, Wagman L, Longmate J, Paz B, Yen Y, Klevecz R.
    Cancer Res; 1998 Jul 01; 58(13):2793-800. PubMed ID: 9661893
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.
    Remick SC, Grem JL, Fischer PH, Tutsch KD, Alberti DB, Nieting LM, Tombes MB, Bruggink J, Willson JK, Trump DL.
    Cancer Res; 1990 May 01; 50(9):2667-72. PubMed ID: 2328492
    [Abstract] [Full Text] [Related]

  • 7. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 May 01; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 8. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
    Qin B, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2006 Jan 01; 57(1):114-9. PubMed ID: 16001177
    [Abstract] [Full Text] [Related]

  • 9. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
    Reid T, Galanis E, Abbruzzese J, Sze D, Wein LM, Andrews J, Randlev B, Heise C, Uprichard M, Hatfield M, Rome L, Rubin J, Kirn D.
    Cancer Res; 2002 Nov 01; 62(21):6070-9. PubMed ID: 12414631
    [Abstract] [Full Text] [Related]

  • 10. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM, Patel NH, Althaus SJ, Coldwell DM, Nghiem HV, Thompson T, Storer B, Thomas CR.
    Clin Cancer Res; 1999 Jan 01; 5(1):95-109. PubMed ID: 9918207
    [Abstract] [Full Text] [Related]

  • 11. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Takeda Y, Hasuike Y, Tsujinaka T.
    Gan To Kagaku Ryoho; 2001 Oct 01; 28(11):1712-7. PubMed ID: 11708016
    [Abstract] [Full Text] [Related]

  • 12. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
    Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ.
    J Clin Oncol; 2006 Mar 20; 24(9):1395-403. PubMed ID: 16505413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC, Kim HC, Lee KH, Yu CS, Kim TW, Chang HM, Ryu MH, Kim JH, Ha HK, Lee MG.
    J Gastroenterol Hepatol; 2006 Jun 20; 21(6):1026-35. PubMed ID: 16724990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
    Maruyama S, Maruyama M, Kato K, Koide A, Ohbu M, Hasegawa K, Takashima I, Ebuchi M.
    Gan To Kagaku Ryoho; 2004 Oct 20; 31(11):1743-5. PubMed ID: 15553701
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of liver metastases of colorectal tumors using intra-arterial fluorouracil via hepatic artery, administered with a completely implantable access system and a portable infusion pump].
    van Groeningen CJ, Meyer S, Vermorken JB, Nieweg MB, Cuesta M, Pinedo HM.
    Ned Tijdschr Geneeskd; 1993 Oct 02; 137(40):2039-43. PubMed ID: 8413719
    [Abstract] [Full Text] [Related]

  • 19. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases.
    Mancini R, Tedesco M, Garufi C, Filippini A, Arcieri S, Caterino M, Pizzi G, Cortesi E, Spila A, Sperduti I, Cosimelli M.
    Anticancer Res; 2003 Aug 01; 23(2C):1837-41. PubMed ID: 12820466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.